stock.name

ImmunityBio Inc

IBRX

Market Cap$2.34B
Close$

Compare ImmunityBio

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ImmunityBio IncImmunityBio Inc-5.10%111%--1.7
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Share Statistics

Market cap$2.34 Billion
Enterprise Value$2.86 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.04
Beta0.0
Outstanding Shares667,705,368
Avg 30 Day Volume4,054,811

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.1
PEG36.86
Price to Sales-
Price to Book Ratio-4.19
Enterprise Value to Revenue5151.87
Enterprise Value to EBIT-7.7
Enterprise Value to Net Income-7
Total Debt to Enterprise0.25
Debt to Equity-1.74

Revenue Sources

No data

ESG Score

No data

About ImmunityBio Inc

171 employees
CEO: Patrick Soon-Shiong

NantKwest (NASDAQ: NK) is an innovative, clinical-stage, immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and infectious diseases. NantKwest is the leading producer of clinical dose forms ...